Locally produced autoantibodies in cancer

Area of Science:

• Oncology
• Immunology
• Biochemistry

Background:

• The role of tumor-infiltrating B cells (TIL-B) in cancer immunity is largely undefined.
• Understanding TIL-B function and antigen specificities is crucial for developing novel cancer therapies.

Purpose of the Study:

• To investigate the role of matrix metalloproteinase 14 (MMP14) in B cell activation and autoantibody production in ovarian cancer.
• To explore the involvement of tertiary lymphoid structures (TLS) in TIL-B mediated anti-tumor responses.

Main Methods:

• Analysis of tumor samples from ovarian cancer patients.
• Characterization of B cell populations within tertiary lymphoid structures.
• Assessment of autoantibody production in response to MMP14.

Main Results:

• Matrix metalloproteinase 14 (MMP14), a self-antigen overexpressed in ovarian tumors, was identified as a driver of B cell activation.
• MMP14 induced autoantibody production by B cells within tertiary lymphoid structures.
• These findings highlight a novel mechanism of B cell involvement in ovarian cancer.

Conclusions:

• Matrix metalloproteinase 14 (MMP14) plays a significant role in activating tumor-infiltrating B cells and promoting autoantibody production in ovarian cancer.
• Tertiary lymphoid structures serve as key sites for these immune responses.
• Targeting MMP14 or associated B cell pathways may offer new therapeutic strategies for ovarian cancer.